Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1-2
pubmed:dateCreated
1994-8-11
pubmed:abstractText
Interleukin 2 (IL2) receptors (IL2R's) are found on malignant cells in many human leukemias and lymphomas and are expressed by activated T cells in many autoimmune disorders. Anti-Tac(Fv), a single-chain protein composed of the variable heavy and light domains of the anti-IL2R monoclonal antibody anti-Tac, can be genetically fused to derivatives of Pseudomonas exotoxin (PE) or diphtheria toxin (DT) to form potent immunotoxins. We have shown that anti-Tac(Fv) binds to low affinity IL2R's on fresh chronic lymphocytic leukemia (CLL) and adult T-cell leukemia (ATL) cells and can target either toxin to kill those cells. Anti-Tac(Fv)-PE40, containing the truncated form of PE without its binding domain, was cytotoxic to malignant cells from 8 of 8 ATL patients tested, with IC50's ranging from 0.11 to 5.5 ng/ml. Anti-Tac(Fv)-PE40KDEL, a derivative of anti-Tac(Fv)-PE40 which contains the KDEL carboxyl terminus, was more cytotoxic toward cells from all ATL patients and also killed CLL cells from 8 of 16 patients. DT388-anti-Tac(Fv), containing amino acids 1-388 of DT fused to the amino terminus of anti-Tac(Fv), was less cytotoxic than anti-Tac(Fv)-PE40 on ATL cells from 4 of 5 patients, but was cytotoxic toward CLL cells from 12 of 16 patients. DT388-IL2, where IL2 is substituted for anti-Tac(Fv), is similar to DAB389IL2, an IL2-toxin currently in clinical trials. DT388-IL2 and DAB389IL2 differ by only a few amino acids and have equal cytotoxic activity. DT388-IL2 was cytotoxic toward ATL cells from all patients tested, but usually required much higher concentrations than anti-Tac(Fv)-PE40 and was poorly active against CLL cells. Thus, recombinant toxins containing anti-Tac(Fv) are cytotoxic toward freshly isolated CLL and ATL cells and will be studied further as potential therapy for IL2R-related disorders.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/ADP Ribose Transferases, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Bacterial Toxins, http://linkedlifedata.com/resource/pubmed/chemical/Diphtheria Toxin, http://linkedlifedata.com/resource/pubmed/chemical/Exotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin Heavy Chains, http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin mu-Chains, http://linkedlifedata.com/resource/pubmed/chemical/Immunotoxins, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Interleukin-2, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Virulence Factors, http://linkedlifedata.com/resource/pubmed/chemical/toxA protein, Pseudomonas aeruginosa
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1042-8194
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1-10
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8025511-ADP Ribose Transferases, pubmed-meshheading:8025511-Amino Acid Sequence, pubmed-meshheading:8025511-Antibodies, Monoclonal, pubmed-meshheading:8025511-Bacterial Toxins, pubmed-meshheading:8025511-Cell Survival, pubmed-meshheading:8025511-Diphtheria Toxin, pubmed-meshheading:8025511-Exotoxins, pubmed-meshheading:8025511-Humans, pubmed-meshheading:8025511-Immunoglobulin Heavy Chains, pubmed-meshheading:8025511-Immunoglobulin mu-Chains, pubmed-meshheading:8025511-Immunotoxins, pubmed-meshheading:8025511-Leukemia, B-Cell, pubmed-meshheading:8025511-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:8025511-Leukemia, T-Cell, pubmed-meshheading:8025511-Leukemia-Lymphoma, Adult T-Cell, pubmed-meshheading:8025511-Molecular Sequence Data, pubmed-meshheading:8025511-Receptors, Interleukin-2, pubmed-meshheading:8025511-Recombinant Proteins, pubmed-meshheading:8025511-Tumor Cells, Cultured, pubmed-meshheading:8025511-Virulence Factors
pubmed:year
1994
pubmed:articleTitle
Recombinant single-chain immunotoxins against T and B cell leukemias.
pubmed:affiliation
Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.
pubmed:publicationType
Journal Article, Review